Search Results - "Isabel Martín-Herranz"
-
1
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV‐infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Published in Basic & clinical pharmacology & toxicology (01-04-2019)“…Two elvitegravir/cobicistat‐based therapies combined with emtricitabine/tenofovir disoproxil fumarate (EVG/c/FTC/TDF) or emtricitabine/tenofovir alafenamide…”
Get full text
Journal Article -
2
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV‐infected Patients: Efficacy, Safety and Tolerance
Published in Basic & clinical pharmacology & toxicology (01-11-2017)“…Two integrase inhibitors (INSTIs), dolutegravir (DTG) and elvitegravir/cobicistat (EVG/COBI), have joined recently the pharmacotherapy arsenal against HIV…”
Get full text
Journal Article -
3
Effectiveness and safety of direct‐acting antivirals in hepatitis C infected patients with mental disorders: Results in real clinical practice
Published in Journal of medical virology (01-12-2020)“…The aim of this study is to analyze the effectiveness and safety of direct‐acting antivirals (DAAs) in psychiatric patients with chronic hepatitis C (CHC)…”
Get full text
Journal Article -
4
-
5
Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
Published in Frontiers in medicine (08-12-2022)“…There is growing evidence that therapeutic drug monitoring of biologic therapy is beneficial in psoriatic patients. With respect to ustekinumab, the available…”
Get full text
Journal Article -
6
Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases
Published in Biomedicines (01-04-2024)“…Measuring biological drugs' trough concentrations and the concentrations of anti-drug antibodies is a valuable practice for treatment optimization. ELISA…”
Get full text
Journal Article -
7
Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines
Published in Journal of the International Association of Providers of AIDS Care (01-01-2019)“…Background: Current HIV treatment guidelines recommend antiretroviral treatment (ART) initiation for all HIV-infected individuals regardless of CD4 count. This…”
Get full text
Journal Article -
8
Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities
Published in Healthcare (Basel) (01-01-2024)“…Early diagnosis of a Human Immunodeficiency Virus (HIV)-infected person represents a cornerstone of HIV prevention, treatment, and care. Numerous publications…”
Get full text
Journal Article -
9
Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases
Published in Journal of clinical pharmacy and therapeutics (01-08-2021)“…What is known and objective Acyclovir and valacyclovir are commonly used antivirals with good general tolerance. Despite their good safety profile, they can…”
Get full text
Journal Article -
10
Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors
Published in AIDS (London) (02-01-2018)“…HIV-1 subtype B (54.4%) and subtype F (27.2%) are the most prevalent variants in patients who started antiretroviral therapy including an integrase inhibitor…”
Get full text
Journal Article -
11
Medication reconciliation for patients after their discharge from intensive care unit to the hospital ward
Published in Farmacia hospitalaria (01-05-2023)“…The aim of this study was to determine whether the transition of care from the intensive care unit to the ward would pose a high risk for reconciliation…”
Get full text
Journal Article -
12
Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients
Published in Therapeutic drug monitoring (01-06-2016)“…To analyze the impact of voriconazole administration on everolimus dose, trough concentrations and concentration/dose (C0/D) ratio in order to determine the…”
Get full text
Journal Article -
13
Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)
Published in Epilepsy & behavior (01-08-2023)“…•Drug-resistant epilepsy (DRE) is considered a severe condition.•DRE is associated with important burden for patients and the healthcare system.•Cenobamate…”
Get full text
Journal Article -
14
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection
Published in European journal of hospital pharmacy. Science and practice (01-05-2023)“…We report the case of a man in his early 70s with idiopathic acquired haemophilia A and persistent high-titre type II inhibitors on immunosuppressive treatment…”
Get full text
Journal Article -
15
[Translated article] Hospital pharmacy towards 2030
Published in Farmacia hospitalaria (01-07-2024)“…Hospital Pharmacy is today a profession marked by therapeutic advances, with a proactive attitude, focussed on people and their health. The evolution of…”
Get full text
Journal Article -
16
Hospital pharmacy towards 2030
Published in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (01-07-2024)“…Hospital pharmacy is today a profession marked by therapeutic advances, with a proactive attitude, focused on people and their health. The evolution of…”
Get more information
Journal Article -
17
Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting
Published in Revista española de quimioterapia (01-06-2021)“…To describe the avoided costs and to analyze the effectiveness of intravenous antibiotic treatment in continuous perfusion in patients at Hospital at Home…”
Get full text
Journal Article -
18
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study
Published in European journal of hospital pharmacy. Science and practice (01-07-2022)“…ObjectivesDespite the high efficacy of antiretroviral treatment, no drug is free from adverse events (AEs). Efavirenz (EFV) and dolutegravir (DTG) are…”
Get full text
Journal Article -
19
Lipid profile changes associated with antiretroviral therapies in a real-world cohort
Published in Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria (01-09-2023)“…To compare lipid profile changes and cardiovascular events among HIV naïve and experienced patients from a real-world cohort treated with…”
Get more information
Journal Article -
20
Lipid profile changes associated with antiretroviral therapies in a real-world cohort
Published in Farmacia hospitalaria (01-09-2023)“…To compare lipid profile changes and cardiovascular events among HIV naïve and experienced patients from a real-world cohort treated with…”
Get full text
Journal Article